OSCR - Company ID 0001568651
The table below shows Oscar Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $4.65B | $2.99B | $2.86B | $3.05B | $2.42B | $2.22B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Oscar Health, Inc. reported annual revenue of $11.70B for fiscal year 2025. That is up 27.5% from $9.18B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $488.19M (FY 2019) to $11.70B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $706.23M |
| $521.59M |
| $534.49M |
| $482.76M |
| $460.38M |
| $435.21M |
| Operating income | $704.09M | -$129.25M | -$230.48M | $297.12M | -$48.37M | $67.81M |
| Income tax | $19.75M | -$1.81M | -$5.04M | $12.71M | $2.08M | $4.64M |
| Net income | $679.00M | -$137.45M | -$228.36M | $275.27M | -$54.60M | $56.21M |
| EPS (diluted) | $2.07 | -$0.53 | -$0.89 | $0.92 | -$0.22 | $0.20 |